Gastric cancer typically develops over many decades, beginning with chronic inflammation in the stomach lining. This can progress to intestinal metaplasia, a condition in which normal stomach cells ...

Gastric cancer (GC) develops through a sequence from chronic gastritis to intestinal metaplasia (IM) and carcinoma, with Helicobacter pylori (HP) as a key driver; however, the molecular mediators ...

ABSTRACT: Introduction: Helicobacter pylori (H. pylori) chronic gastritis is an infectious disease causing chronic histological changes in the gastric mucosa. It is a ubiquitous condition, but is more ...

ABSTRACT: Introduction: Helicobacter pylori (H. pylori) chronic gastritis is an infectious disease causing chronic histological changes in the gastric mucosa. It is a ubiquitous condition, but is more ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

The intestinal parasite Cryptosporidium is a vicious trespasser, hiding within the cells that line the gut and causing intestinal damage. "Cryptosporidium infections can be life-threatening, ...

Background Gastric intestinal metaplasia (GIM), particularly the incomplete subtype (Inc IM), is strongly associated with increased gastric cancer (GC) risk. However, its role as a true precursor ...

Gastric cancer remains a major global health challenge, representing the fifth most commonly diagnosed cancer and the fourth leading cause of cancer-related mortality worldwide. In 2020, gastric ...

A phase II study of perioperative intraperitoneal paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology. Total neoadjuvant therapy with induction ...